Formulation and In-Vitro Evaluation of Gastro Retentive Floating Drug Delivery System of Losartan Potassium.

K.S. Srilatha, Hemanth. S, B. Milton, Snehalatha
{"title":"Formulation and In-Vitro Evaluation of Gastro Retentive Floating Drug Delivery System of Losartan Potassium.","authors":"K.S. Srilatha, Hemanth. S, B. Milton, Snehalatha","doi":"10.46624/ajphr.2020.v8.i4.003","DOIUrl":null,"url":null,"abstract":"The objective of the study was to formulate and evaluate gastro retentive floating drug delivery tablets of Losartan potassium. It is an orally active non-peptide angiotensin -II receptor antagonist, used in the treatment of hypertension due to mainly blockade of AT1 receptors. The main reason for low therapeutic effectiveness of Losartan potassium is its narrow therapeutic index, poor bioavailability (25-35%), and short biological half life (1.5-2h). Conventional tablets should be administered 3-4 times to maintain plasma drug concentration. So, to increase therapeutic efficacy, reduce frequency of administration sustained release floating matrix tablets of Losartan potassium were prepared. Present study demonstrates the formulation of sustained release floating matrix tablets of Losartan potassium with various grades of hydroxyl propyl methylcellulose to restrict the drug release preferably in upper part of intestine and to improve its bioavailability and to provide constant drug plasma levels thereby improving the patient compliance. Losartan potassium showed maximum absorbance at 256 nm so absorbance was measured at the same wavelength and found to obey Beer lamberts law in the concentration range of 10-40 mcg/ml. In the pre formulation study of IR spectra of pure drug with the different polymers showed no interaction, Differential scanning calorimetry experiments were carried out to find out the presence of any interaction among drug and the excipients. Pure drug and individual polymers were subjected to the study and no interactions were observed .12 formulation of sustained release of Losartan potassium were prepared and they were examined for physical properties and appearance like hardness, thickness, weight variation, thickness, hardness, friability uniformity of drug content floating lag time floating duration time and in-vitro drug release studies . I n the study all the powder blends showed good flow ability angle of repose below 25.98±0.07°31.724±0.15°, compressibility index was found in the range of 12.5±0.1616.92±1.9 g/cm Weight variation 297.2±1.19-301.52±2.73mg, hardness 5.9±0.2-7±0.2kg/cm thickness 4.506±0.04-4.86±0.03, friability 0.91-0.41, floating time <12hrs in vitro release for all formulations were found to be 61.18 -99.02.","PeriodicalId":7701,"journal":{"name":"American Journal of PharmTech Research","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2020-04-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of PharmTech Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.46624/ajphr.2020.v8.i4.003","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The objective of the study was to formulate and evaluate gastro retentive floating drug delivery tablets of Losartan potassium. It is an orally active non-peptide angiotensin -II receptor antagonist, used in the treatment of hypertension due to mainly blockade of AT1 receptors. The main reason for low therapeutic effectiveness of Losartan potassium is its narrow therapeutic index, poor bioavailability (25-35%), and short biological half life (1.5-2h). Conventional tablets should be administered 3-4 times to maintain plasma drug concentration. So, to increase therapeutic efficacy, reduce frequency of administration sustained release floating matrix tablets of Losartan potassium were prepared. Present study demonstrates the formulation of sustained release floating matrix tablets of Losartan potassium with various grades of hydroxyl propyl methylcellulose to restrict the drug release preferably in upper part of intestine and to improve its bioavailability and to provide constant drug plasma levels thereby improving the patient compliance. Losartan potassium showed maximum absorbance at 256 nm so absorbance was measured at the same wavelength and found to obey Beer lamberts law in the concentration range of 10-40 mcg/ml. In the pre formulation study of IR spectra of pure drug with the different polymers showed no interaction, Differential scanning calorimetry experiments were carried out to find out the presence of any interaction among drug and the excipients. Pure drug and individual polymers were subjected to the study and no interactions were observed .12 formulation of sustained release of Losartan potassium were prepared and they were examined for physical properties and appearance like hardness, thickness, weight variation, thickness, hardness, friability uniformity of drug content floating lag time floating duration time and in-vitro drug release studies . I n the study all the powder blends showed good flow ability angle of repose below 25.98±0.07°31.724±0.15°, compressibility index was found in the range of 12.5±0.1616.92±1.9 g/cm Weight variation 297.2±1.19-301.52±2.73mg, hardness 5.9±0.2-7±0.2kg/cm thickness 4.506±0.04-4.86±0.03, friability 0.91-0.41, floating time <12hrs in vitro release for all formulations were found to be 61.18 -99.02.
氯沙坦钾胃保留漂浮给药系统的研制及体外评价。
本研究的目的是研制氯沙坦钾胃保留漂浮给药片并对其进行评价。它是一种口服活性的非肽血管紧张素-II受体拮抗剂,主要用于治疗因阻断AT1受体而导致的高血压。氯沙坦钾治疗效果低的主要原因是治疗指数窄,生物利用度差(25-35%),生物半衰期短(1.5-2h)。常规片剂应服用3-4次,以维持血药浓度。为提高疗效,减少给药次数,研制氯沙坦钾缓释片。本研究证明了氯沙坦钾缓释片与不同等级羟丙基甲基纤维素的配方,以限制药物在肠道上部的释放,提高其生物利用度,并提供恒定的血浆药物水平,从而提高患者的依从性。氯沙坦钾在256 nm处吸光度最大,在同一波长测量吸光度,在10 ~ 40 mcg/ml浓度范围内符合比尔兰伯特定律。在制剂前研究中,对纯药物与不同聚合物的红外光谱均未发现相互作用,进行差示扫描量热实验,以确定药物与辅料之间是否存在相互作用。制备了12种氯沙坦钾缓释制剂,并对其进行了硬度、厚度、重量变化、厚度、硬度、药物含量的脆性均匀性、漂浮滞后时间、漂浮持续时间和体外释放等物理性能和外观研究。在本研究中,所有粉末共混物均表现出良好的流动能力,休止角小于25.98±0.07°31.724±0.15°,压缩指数为12.5±0.1616.92±1.9 g/cm,重量变化为297.2±1.19 ~ 301.52±2.73mg,硬度为5.9±0.2 ~ 7±0.2kg/cm,厚度为4.506±0.04 ~ 4.86±0.03,脆度为0.91 ~ 0.41,漂浮时间<12h,体外释放度为61.18 ~ 99.02。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信